Data / Drug companies / Chlorthalidone
Chlorthalidone: 42 companies and 105 products in the FDA NDC directory
Chlorthalidone is listed in the FDA National Drug Code Directory by 42 companies, with 105 products in commercial distribution. 103 of the products (98.1%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, and the newest product started marketing on September 21, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 42
- Products
- 105
- Generic (ANDA) products
- 103 (98.1%)
- Application numbers
- 20
- Routes
- Oral
- Brand names
- Hemiclor, Thalitone
- openFDA record search
- api.fda.gov
Companies that list chlorthalidone
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Bryant Ranch Prepack | 11 | tablet | Generic drugs (ANDA) | October 23, 2024 |
| A-S Medication Solutions | 6 | tablet | Generic drugs (ANDA) | May 20, 2021 |
| Bryant Ranch Prepack | 5 | tablet | Generic drugs (ANDA) | August 5, 2022 |
| Northwind Health Company, LLC | 5 | tablet | Generic drugs (ANDA) | December 2, 2022 |
| Aphena Pharma Solutions - Tennessee, LLC | 4 | tablet | Generic drugs (ANDA) | October 20, 2022 |
| Dr. Reddy's Laboratories Inc. | 4 | tablet | Generic drugs (ANDA) | October 20, 2022 |
| Preferred Pharmaceuticals Inc. | 4 | tablet | Generic drugs (ANDA) | July 24, 2026 |
| Rising Pharma Holdings, Inc. | 4 | tablet | Generic drugs (ANDA) | October 23, 2024 |
| Bryant Ranch Prepack | 3 | tablet | Generic drugs (ANDA) | August 5, 2022 |
| Direct_Rx | 3 | tablet | Generic drugs (ANDA) | October 1, 2025 |
| Remedyrepack Inc. | 3 | tablet | Generic drugs (ANDA) | March 4, 2026 |
| Ajanta Pharma USA Inc. | 2 | tablet | Generic drugs (ANDA) | May 20, 2021 |
| Alembic Pharmaceuticals Inc. | 2 | tablet | Generic drugs (ANDA) | August 29, 2022 |
| Alembic Pharmaceuticals Limited | 2 | tablet | Generic drugs (ANDA) | August 29, 2022 |
| Amneal Pharmaceuticals LLC | 2 | tablet | Generic drugs (ANDA) | July 1, 2019 |
| Ascend Laboratories, LLC | 2 | tablet | Generic drugs (ANDA) | February 13, 2020 |
| Chartwell RX, LLC | 2 | tablet | Generic drugs (ANDA) | February 26, 2019 |
| Coupler LLC | 2 | tablet | Generic drugs (ANDA) | January 28, 2025 |
| Ipca Laboratories Limited | 2 | tablet | Generic drugs (ANDA) | September 21, 2026 |
| Jubilant Cadista Pharmaceuticals Inc. | 2 | tablet | Generic drugs (ANDA) | March 31, 2021 |
| Lifestar Pharma LLC | 2 | tablet | Generic drugs (ANDA) | August 5, 2022 |
| Macleods Pharmaceuticals Limited | 2 | tablet | Generic drugs (ANDA) | July 1, 2026 |
| Major Pharmaceuticals | 2 | tablet | Generic drugs (ANDA) | January 12, 2026 |
| Mylan Pharmaceuticals Inc. | 2 | tablet | Generic drugs (ANDA) | February 26, 1981 |
| Nivagen Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | May 28, 2018 |
| NorthStar Rx LLC | 2 | tablet | Generic drugs (ANDA) | November 21, 2019 |
| PD-Rx Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | October 27, 2023 |
| Sun Pharmaceutical Industries, Inc. | 2 | tablet | Generic drugs (ANDA) | February 12, 2016 |
| Tagi Pharma, Inc. | 2 | tablet | Generic drugs (ANDA) | August 5, 2022 |
| Umedica Laboratories USA Inc. | 2 | tablet | Generic drugs (ANDA) | February 15, 2026 |
| Unichem Pharmaceuticals (USA), Inc. | 2 | tablet | Generic drugs (ANDA) | August 6, 2019 |
| Zydus Lifesciences Limited | 2 | tablet | Generic drugs (ANDA) | May 15, 2019 |
| Zydus Pharmaceuticals USA Inc. | 2 | tablet | Generic drugs (ANDA) | May 15, 2019 |
| American Health Packaging | 1 | tablet | Generic drugs (ANDA) | August 10, 2017 |
| AvPAK | 1 | tablet | Generic drugs (ANDA) | November 12, 2019 |
| Casper Pharma LLC | 1 | tablet | New drug applications (NDA) | November 27, 2019 |
| Ingenus Pharmaceuticals, LLC | 1 | tablet | New drug applications (NDA) | March 17, 2025 |
| Mylan Institutional Inc. | 1 | tablet | Generic drugs (ANDA) | June 12, 1998 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | February 26, 1981 |
| Proficient Rx LP | 1 | tablet | Generic drugs (ANDA) | February 13, 2020 |
| Proficient Rx LP | 1 | tablet | Generic drugs (ANDA) | May 28, 2018 |
| Safecor Health, LLC | 1 | tablet | Generic drugs (ANDA) | March 26, 2026 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 105 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 103 | 98.1% |
| New drug applications (NDA) | 2 | 1.9% |
Pharmacologic classes
| Class | Products |
|---|---|
| Thiazide-like Diuretic | 105 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.